65 related articles for article (PubMed ID: 35214646)
21. HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010-2021): a retrospective study.
Na YJ; Jeong O; Seong J; Lee J; Lee SY; Hur S; Ryou S
J Gynecol Oncol; 2024 Jan; ():. PubMed ID: 38330379
[TBL] [Abstract][Full Text] [Related]
22. High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines.
Bowden SJ; Ellis LB; Kyrgiou M; Fiander AN; Hibbitts S
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298619
[TBL] [Abstract][Full Text] [Related]
23. Caring for the Unvaccinated.
Parker WF
Ann Am Thorac Soc; 2022 Feb; 19(2):153-156. PubMed ID: 34860642
[No Abstract] [Full Text] [Related]
24. Prevalence of Human Papillomavirus Types 16/18 and Effect of Vaccination among Japanese Female General Citizens in the Vaccine Crisis Era.
Kitamura T; Suzuki M; Shigehara K; Fukuda K; Matsuyama T; Kume H
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680199
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus (HPV) integration signature in cervical lesions: identification of MACROD2 gene as HPV hot spot integration site.
Zhao J; Zheng W; Wang L; Jiang H; Wang X; Hou J; Xu A; Cong J
Arch Gynecol Obstet; 2023 Apr; 307(4):1115-1123. PubMed ID: 36008642
[TBL] [Abstract][Full Text] [Related]
26. Japan's Ongoing Crisis on HPV Vaccination.
Sekine M; Kudo R; Yamaguchi M; Hanley SJB; Hara M; Adachi S; Ueda Y; Miyagi E; Ikeda S; Yagi A; Enomoto T
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32640691
[No Abstract] [Full Text] [Related]
27. Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program.
Onuki M; Yamamoto K; Yahata H; Kanao H; Horie K; Konnai K; Nio A; Takehara K; Kamiura S; Tsuda N; Takei Y; Shigeta S; Nakai H; Yoshida H; Motohara T; Kato T; Nakamura K; Hamanishi J; Tasaka N; Ishikawa M; Kado N; Taira Y; Mori M; Iwata T; Takahashi F; Kukimoto I; Yoshikawa H; Yaegashi N; Matsumoto K; For The Mint Study Group
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214646
[TBL] [Abstract][Full Text] [Related]
28. Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program.
Matsumoto K; Yaegashi N; Iwata T; Yamamoto K; Aoki Y; Okadome M; Ushijima K; Kamiura S; Takehara K; Horie K; Tasaka N; Sonoda K; Takei Y; Aoki Y; Konnai K; Katabuchi H; Nakamura K; Ishikawa M; Watari H; Yoshida H; Matsumura N; Nakai H; Shigeta S; Takahashi F; Noda K; Yoshikawa H;
Cancer Sci; 2019 Dec; 110(12):3811-3820. PubMed ID: 31596999
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
Onuki M; Matsumoto K; Iwata T; Yamamoto K; Aoki Y; Maenohara S; Tsuda N; Kamiura S; Takehara K; Horie K; Tasaka N; Yahata H; Takei Y; Aoki Y; Kato H; Motohara T; Nakamura K; Ishikawa M; Kato T; Yoshida H; Matsumura N; Nakai H; Shigeta S; Takahashi F; Noda K; Yaegashi N; Yoshikawa H
Cancer Sci; 2020 Jul; 111(7):2546-2557. PubMed ID: 32372453
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women.
Onuki M; Yamamoto K; Yahata H; Kanao H; Yokota H; Kato H; Shimamoto K; Takehara K; Kamiura S; Tsuda N; Takei Y; Shigeta S; Matsumura N; Yoshida H; Motohara T; Watari H; Nakamura K; Ueda A; Tasaka N; Ishikawa M; Hirashima Y; Kudaka W; Taguchi A; Iwata T; Takahashi F; Kukimoto I; Yoshikawa H; Yaegashi N; Matsumoto K;
Cancer Sci; 2022 Apr; 113(4):1428-1434. PubMed ID: 35043515
[TBL] [Abstract][Full Text] [Related]
31. HPV type-specific trends in cervical precancers in the United States, 2008 to 2016.
Gargano JW; McClung N; Lewis RM; Park IU; Whitney E; Castilho JL; Pemmaraju M; Niccolai LM; Brackney M; DeBess E; Ehlers S; Bennett NM; Scahill M; Cleveland AA; Querec TD; Unger ER; Markowitz LE;
Int J Cancer; 2023 Jan; 152(2):137-150. PubMed ID: 35904861
[TBL] [Abstract][Full Text] [Related]
32. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
[TBL] [Abstract][Full Text] [Related]
33. A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan.
Yagi A; Ueda Y; Nakagawa S; Masuda T; Miyatake T; Ikeda S; Abe H; Hirai K; Sekine M; Miyagi E; Enomoto T; Nakayama T; Kimura T
Cancer Sci; 2021 Sep; 112(9):3691-3698. PubMed ID: 34252250
[TBL] [Abstract][Full Text] [Related]
34. Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects.
Hoes J; Woestenberg PJ; Bogaards JA; King AJ; de Melker HE; Berkhof J; Hoebe CJPA; van der Sande MAB; van Benthem BHB;
Clin Infect Dis; 2021 Mar; 72(5):e103-e111. PubMed ID: 33249475
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
